EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Long-Acting Injectable Antipsychotics and Time to Readmission in Early Psychosis

Caroline Wang iD, Sean Lynch, Chaden Noureddine, Natalie Burlant, Nishtha Ahuja, Koki Haruguchi, Sungmin Hong, Manuela Zisu, Lisa Cohen, Timothy Rice, Ashley Sterchele

Journal of Child and Adolescent Psychopharmacology · 01.06.2026 · 36 (5) · 297-303

DOI: 10.1177/10445463261440387 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, online erschienen am 07.04.2026. Verfasst von Caroline Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Patient Readmission, Psychotic Disorders, Antipsychotic Agents. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long-acting injectable (LAI) antipsychotics have demonstrated benefits in reducing relapse and hospitalization in psychotic disorders, yet their real-world impact in early-phase psychosis remains incompletely understood. This study examined baseline characteristics, hospitalization features, and postdischarge outcomes among young patients with early psychosis treated with LAI versus oral (PO) antipsychotics.

Methods

This retrospective chart review included 229 patients under age 25 hospitalized for psychosis at a multicenter health system between 2018 and 2022. Patients receiving LAI ( N = 144) were compared with those receiving PO antipsychotics ( N = 85) on sociodemographic, clinical, and admission variables. The primary outcome was psychiatric readmission within 1 year of discharge. Secondary outcomes included time to readmission, which was analyzed using Kaplan–Meier survival analysis. Multivariable logistic regression evaluated whether LAI treatment independently predicted readmission after adjusting for length of stay, prior hospitalizations, and undomiciled status.

Results

The LAI group was older and exhibited greater clinical and social risk, including more prior hospitalizations, higher rates of undomiciled status, and more suicide attempts. They also had longer inpatient stays and greater medication complexity during hospitalization. One-year readmission rates were similar between groups (30.6% LAI vs. 24.7% PO). Among readmitted patients, the LAI group showed longer time to readmission. In adjusted analyses, LAI treatment was not independently associated with readmission. Undomiciled status was independently associated with readmission, paradoxically in the direction of lower odds.

Conclusions

For young patients with early psychosis, LAIs were preferentially prescribed to higher-risk patients but were not independently associated with reduced 1-year readmission. Comparable outcomes between groups despite greater baseline risk in the LAI cohort suggest that LAIs may partially mitigate elevated risk, though this interpretation requires prospective confirmation. Housing instability emerged as a critical determinant of readmission patterns, underscoring the need for integrated pharmacologic and social interventions in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient ReadmissionPsychotic DisordersAntipsychotic AgentsHumansFemaleRetrospective StudiesDelayed-Action PreparationsMaleAdolescentTime FactorsAdministration, OralInjectionsYoung AdultHospitalizationLength of Stay

Stichwörter der Autor:innen

antipsychoticsearly psychosislong-acting injectablesreadmission

Substanzen

Antipsychotic AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Psychiatry, Mount Sinai Behavioral Health Center, New York, New York, USA.
  • Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

ORCID-Profile: Caroline Wang

Förderung

  • NIDA NIH HHS

Zitieren

APA

Wang, C., Lynch, S., Noureddine, C., Burlant, N., Ahuja, N., Haruguchi, K., Hong, S., Zisu, M., Cohen, L., Rice, T., & Sterchele, A. (2026). Long-Acting Injectable Antipsychotics and Time to Readmission in Early Psychosis. Journal of Child and Adolescent Psychopharmacology, 36(5), 297-303. https://doi.org/10.1177/10445463261440387

Vancouver

Wang C, Lynch S, Noureddine C, Burlant N, Ahuja N, Haruguchi K, et al. Long-Acting Injectable Antipsychotics and Time to Readmission in Early Psychosis. Journal of Child and Adolescent Psychopharmacology. 2026;36(5):297-303. doi:10.1177/10445463261440387

BibTeX
@article{Wang2026,
  author = {Wang, Caroline and Lynch, Sean and Noureddine, Chaden and Burlant, Natalie and Ahuja, Nishtha and Haruguchi, Koki and Hong, Sungmin and Zisu, Manuela and Cohen, Lisa and Rice, Timothy and Sterchele, Ashley},
  title = {Long-Acting Injectable Antipsychotics and Time to Readmission in Early Psychosis},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2026},
  volume = {36},
  number = {5},
  pages = {297--303},
  doi = {10.1177/10445463261440387}
}
Kostenlos starten →